04.20.16
Bioclinica, Inc., a specialty clinical trials technology and services provider, has selected ArisGlobal's Safety Cloud as the preferred platform for its pharmacovigilance services. Bioclinica becomes the preferred partner for ArisGlobal in business process consulting and change management as sponsors implement or upgrade ARISg. The partnership aims to provide a flexible delivery model for any size organization.
A top 20 pharma company has selected Bioclinica to standardize its safety case processing service on the ArisGlobal platform, while two other companies are making the switch from competing platforms. "Early adoption speaks to the strength and value of our joint solution in addressing industry's long-wanted desire for such a safety offering," said Bioclinica president of eHealth Solutions, Mukhtar Ahmed.
ArisGlobal vice president of safety George Philips said, "Through our partnership with Bioclinica, we are able to provide the pharmaceutical industry with an unprecedented level of streamlined and cost efficient end-to-end pharmacovigilance services." The cloud-based solution replaces traditional on premise safety systems unpopular with many organizations due to burdensome management, maintenance, and fiscal challenges. "By utilizing these services, resources within an organization can now be shifted to address other pressing needs."
ArisGlobal and Bioclinica's Safety and Regulatory Solutions division formulated this partner strategy in an effort to deliver cost-effective and regulatory compliant services. Bioclinica's Global Consulting group provides business and change management expertise when implementing or upgrading to new versions of ARISg, including ROI optimization, SOP creation, system validation and development of agile database conventions.
"The formation of this partnership addresses the full continuum of pharmacovigilance as a service," Mr. Ahmed remarked. "Together Bioclinica and ArisGlobal provide the most comprehensive solution, whether an organization wants to handle safety internally or outsource it to our team of safety experts."
A top 20 pharma company has selected Bioclinica to standardize its safety case processing service on the ArisGlobal platform, while two other companies are making the switch from competing platforms. "Early adoption speaks to the strength and value of our joint solution in addressing industry's long-wanted desire for such a safety offering," said Bioclinica president of eHealth Solutions, Mukhtar Ahmed.
ArisGlobal vice president of safety George Philips said, "Through our partnership with Bioclinica, we are able to provide the pharmaceutical industry with an unprecedented level of streamlined and cost efficient end-to-end pharmacovigilance services." The cloud-based solution replaces traditional on premise safety systems unpopular with many organizations due to burdensome management, maintenance, and fiscal challenges. "By utilizing these services, resources within an organization can now be shifted to address other pressing needs."
ArisGlobal and Bioclinica's Safety and Regulatory Solutions division formulated this partner strategy in an effort to deliver cost-effective and regulatory compliant services. Bioclinica's Global Consulting group provides business and change management expertise when implementing or upgrading to new versions of ARISg, including ROI optimization, SOP creation, system validation and development of agile database conventions.
"The formation of this partnership addresses the full continuum of pharmacovigilance as a service," Mr. Ahmed remarked. "Together Bioclinica and ArisGlobal provide the most comprehensive solution, whether an organization wants to handle safety internally or outsource it to our team of safety experts."